EUVIMEDEUVIMED entdecken
Crossref

Norcantharidin inhibits the METTL16/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer

Yuan-Yuan Zhang, Qiu-Xia Zeng, Li Wang, Kong-Xian Li, Shun Zhang, Ping Wan, Xue-Ming Zhou, Qi Chen

Archives of Biochemistry and Biophysics · 2025

DOI: 10.1016/j.abb.2025.110510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Yuan-Yuan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi Province, People's Republic of…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Methyltransferases, Apoptosis, Methionine Adenosyltransferase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Jiangxi Institute of Traditional Chinese Medicine, Health and Family Planning Commission of Jiangxi Province, Health Commission of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to investigate the antitumor effects of norcantharidin (NCTD) in ovarian cancer and to elucidate its molecular targets and mechanisms of action, with a focus on the methyltransferase-like protein 16 (METTL16)/methionine adenosyl transferase II alpha (MAT2A) signaling axis. MATERIALS AND METHODS: Expression levels of METTL16 and MAT2A were analyzed in ovarian cancer tissues and cells using immunohistochemistry, quantitative real-time polymerase chain reaction, and western blotting. Human ovarian cancer cell lines (ES2 and SKOV3) were cultured and subjected to METTL16 overexpression via gene recombination. The cytotoxic effects of varying concentrations of NCTD were assessed using the Cell Counting Kit-8 assay. Apoptosis, proliferation, and migration were evaluated through flow cytometry and wound healing (scratch) assays. A subcutaneous xenograft model of human ovarian cancer was established in nude mice to assess in vivo antitumor efficacy. Enzyme-linked immunosorbent assay was used to quantify intracellular levels of S-adenosylmethionine (SAM). RESULTS: METTL16 and MAT2A gene expression levels were significantly elevated in ovarian cancer tissues and cell lines (p < 0.05). Treatment with NCTD at 10 μg/mL significantly inhibited proliferation and induced apoptosis in ES2 and SKOV3 cells. NCTD also suppressed cellular migration and angiogenic activity, with downregulation of related gene expression, effects that were attenuated by METTL16 overexpression (p < 0.05). In the xenograft model, NCTD administration significantly reduced tumor volume and downregulated expression of METTL16, MAT2A, protein phosphatase 2A (PP2A), and vascular endothelial growth factor (p < 0.05). CONCLUSIONS: NCTD exerts antineoplastic effects in ovarian cancer by reducing intracellular S-adenosylmethionine levels, promoting PP2A demethylation, and inhibiting the METTL16/MAT2A signaling pathway. These effects contribute to cell cycle arrest, suppressed proliferation, and enhanced apoptosis, supporting the therapeutic potential of NCTD in ovarian malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsMethyltransferasesApoptosisMethionine AdenosyltransferaseBridged Bicyclo Compounds, HeterocyclicAntineoplastic AgentsFemaleHumansAnimalsCell Line, TumorMiceSignal TransductionCell ProliferationMice, NudeCell MovementXenograft Model Antitumor AssaysDisease ProgressionS-AdenosylmethionineGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Methionine adenosyltransferase 2AMethyltransferase-like protein 16NorcantharidinOvarian cancerS-adenosylmethionine

Substanzen

MethyltransferasesnorcantharidinMethionine AdenosyltransferaseBridged Bicyclo Compounds, HeterocyclicMAT2A protein, humanAntineoplastic AgentsS-Adenosylmethionine

Autor:innen und Institutionen

  • Department of Obstetrics & Gynecology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi Province, People's Republic of China.
  • Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi Province, People's Republic of China.
  • Department of Gynecology of Traditional Chinese Medicine, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, Jiangxi Province, People's Republic of China.
  • Department of Traditional Chinese Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi Province, People's Republic of China.
  • Department of Obstetrics & Gynecology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi Province, People's Republic of China. Electronic address: chenqicq991@126.com.

Förderung

  • Jiangxi Institute of Traditional Chinese Medicine
  • Health and Family Planning Commission of Jiangxi Province
  • Health Commission of Jiangxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y. Y., Zeng, Q. X., Wang, L., Li, K. X., Zhang, S., Wan, P., Zhou, X. M., & Chen, Q. (2025). Norcantharidin inhibits the METTL16/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110510

Vancouver

Zhang YY, Zeng QX, Wang L, Li KX, Zhang S, Wan P, et al. Norcantharidin inhibits the METTL16/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110510

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuan-Yuan and Zeng, Qiu-Xia and Wang, Li and Li, Kong-Xian and Zhang, Shun and Wan, Ping and Zhou, Xue-Ming and Chen, Qi},
  title = {Norcantharidin inhibits the METTL16/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1016/j.abb.2025.110510}
}
Kostenlos starten →